🎉Thrilled to announce that my lab is officially established.
Looking forward to groundbreaking discoveries and collaborations ahead.
Welcome all friends and colleagues to visit and exchange ideas!🎉
It is with sadness that we acknowledge the passing of Dr. James Watson, Nobel prize-winning scientist and former Director and President of CSHL. We extend our sincere condolences to his wife Liz and family during this difficult time. We recognize Dr. Watson’s incredible contributions to science and the research community. More on Dr. Watson’s legacy with CSHL can be found on our website. https://t.co/s6ZWiP621D
Amazing Keynote Session at the 14th Annual Symposium @FoxChaseCancer by Dr. Avram Hershko, 2004 Nobel Prize in Chemistry. Inspiring to hear the incredible story behind the discovery of ubiquitin-mediated protein degradation at Fox Chase!
Differentiation therapy is a relatively new approach to treating cancer that works by “normalizing” cancer cells. And a study published by Fox Chase researchers demonstrates that this approach could be an effective treatment for medulloblastoma: https://t.co/o0kVfu7D0d
Differentiation therapy is a relatively new approach to treating cancer that works by “normalizing” cancer cells. And a study published by Fox Chase researchers demonstrates that this approach could be an effective treatment for medulloblastoma: https://t.co/o0kVfu7D0d
Afternoon session launches after a vibrant lunch and poster session at #CEI2024Symp
Now the CEI C. David Allis Travel Award recipients from 2023 are presenting their discoveries, which highlights the NEXT Gen of Epigenetic scientist. CONGRATS- Manna and Boris!
Medulloblastoma is the most common malignant brain tumor in children, and few good treatment options exist. Now, researchers at Fox Chase Cancer Center have found a promising new approach using a drug that’s already being used to treat hypothyroidism: https://t.co/zODsxmDKn6
So Proud! Our lab members won best posters by popular vote @CeiFccc#CEI2023Symp!!! Great job @madisonahoner , Ben, Zach and @GulnazAlekbaewa
Congrats Boris and Haley for also winning Poster Prizes!
We're proud to be a founding member of the @NCCN! This alliance of leading cancer centers has dedicated its mission to improving the quality & effectiveness of care provided to patients with cancer. More on their history as they celebrate 25 yrs here: https://t.co/ZhEBPVHHOK.
One of our postdoctoral researchers, Yijun Yang, PhD, is lobbying today for continued support from our legislators for #Funding4CURE. Learn more about Yijun's research investigating #medulloblastoma, the most common malignant brain tumor in children: https://t.co/LQ0XGQ5dbU.